Results 31 to 40 of about 5,648 (180)

Mature T‐cell leukemia/lymphoma with an NK‐like immunophenotype: A report of 7 cases

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Distinguishing T‐cell from NK‐cell neoplasms can occasionally be challenging, as neoplastic T cells can lose T‐cell markers such as surface CD3 (sCD3) and CD5 while acquiring NK‐cell markers such as CD16, CD56, and CD94. In this study, we present a series of 7 mature T‐cell lymphoma/leukemia cases with NK‐like immunophenotypes to clarify ...
Wei J. Wang, Sa A. Wang, Hong Fang, Jeffrey L. Jorgensen, Shimin Hu, Lianqun Qiu, Jie Xu, L. Jeffrey Medeiros, Wei Wang   +8 more
wiley   +1 more source

Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.

PLoS ONE, 2016
BackgroundThe goal of this study was to perform a systematic review to examine the efficacy and safety of various salvage therapy regimens on patients with relapsed/refractory PTCL.MethodThe electronic searches were performed using PubMed, Cochrane ...
Ya-Ting Yang, Cheng-Jeng Tai, Chiehfeng Chen, Hong-Cheng Wu, Natalia Mikhaylichenko, Hsien-Tsai Chiu, Yun-Yi Chen, Yi-Hsin Elsa Hsu   +7 more
doaj   +1 more source

Single Atom‐Modified TiO2‐Based Catalysts for Photoelectrochemical Water Splitting: From Fundamentals to Future Prospects

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Hydrogen and oxygen generated from water splitting process by photoelectrocatalysis of single atom modified TiO2 based photoelectrocatalysts. The accelerating demand for green hydrogen has intensified the development of efficient and durable photoelectrocatalysts (PECs) for sustainable water splitting.
Zichu Zhao, Cheryl Suwen Law, Abel Santos   +2 more
wiley   +1 more source

Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)

Blood
Abstract The treatment of common nodal peripheral T-cell lymphomas (PTCLs), including PTCL, not otherwise specified (PTCL, NOS), anaplastic large-cell lymphomas, and T-follicular helper lymphomas, is evolving.
Alison J. Moskowitz, Robert N. Stuver, Steven M. Horwitz   +2 more
openaire   +3 more sources

Cyclometalated Au(III) Complexes With C*N^N, N^C*N, and C*N Ligands Through C–H Activation

Zeitschrift für anorganische und allgemeine Chemie, EarlyView.
The complexes [Au(QPhPy)Cl][AuCl4], [Au(QPhCF3Py)Cl][AuCl4], [Au(QPhtBuPy)Cl][AuCl4], [Au(QPhPy)Cl]Cl, [Au(QPyPh)Cl2], [Au(QPyPhCF3)Cl2], [Au(QPyPhtBu)Cl2], [Au(bpyAn)Cl][AuCl4], and [Au(phenAn)Cl][AuCl4] (Q = 8‐quinolinyl, Ph = phenyl, An = anthracen‐9‐yl, Py = pyridyl, bpy = 2,2′′‐bipyridyl, phen = 1,10‐phenanthrolinyl) containing N*C^N, N*C, and NN ...
Pascal L. Jurzick, Leo Payen, Bruno Poti e Silva, Francisco Luan Rodrigues Lino, Vladimir Stojadinovic, Axel Klein   +5 more
wiley   +1 more source

The gene expression profile and cell of origin of canine peripheral T-cell lymphoma

BMC Cancer
Background Peripheral T-cell lymphoma (PTCL) refers to a heterogenous group of T-cell neoplasms with poor treatment responses and survival times. Canine PTCL clinically and immunophenotypically resembles the most common human subtype, PTCL-not otherwise ...
Eileen Owens, Lauren Harris, Adam Harris, Janna Yoshimoto, Robert Burnett, Anne Avery   +5 more
doaj   +1 more source

Development of dynamical network biomarkers for regulation in Epstein-Barr virus positive peripheral T cell lymphoma unspecified type

Frontiers in Genetics, 2022
Background: This study was performed to identify key regulatory network biomarkers including transcription factors (TFs), miRNAs and lncRNAs that may affect the oncogenesis of EBV positive PTCL-U.Methods: GSE34143 dataset was downloaded and analyzed to ...
Dan Shen, Yin Hong, Zhengyang Feng, Xiangying Chen, Yuxing Cai, Qiliang Peng, Jian Tu   +6 more
doaj   +1 more source

Dual PI3K blockade: PTCL’s Achilles heel? [PDF]

Blood, 2018
In this issue of Blood, 2 companion articles by Flinn et al1 and Horwitz et al2 present promising phase 1 data demonstrating clinical efficacy of the dual inhibitor of phosphatidylinositol 3-kinase (PI3K)-δ and PI3K-γ duvelisib in patients with advanced hematologic malignancies, including T-cell lymphomas (TCLs).
openaire   +2 more sources

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore, Madeleine Neildez, Adèle de Masson, Maxime Battistella, Marie Tauber, Saskia Ingen‐Housz‐Oro, Catherine Droitcourt, Delphine Staumont‐Sallé, Marie Beylot‐Barry   +8 more
wiley   +1 more source

Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group

JCO Global Oncology
PURPOSEPeripheral T-cell lymphomas (PTCLs) encompass a group of rare and diverse disease entities for which contemporary frontline treatment options are limited. Patient outcomes for PTCL remain poor globally, and disparities in health care resources and
Jason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, Gin Gin Gan, Sen Mui Tan, Soo Chin Ng, Kian Meng Chang, Priscilla Caguioa, Jay Datukan, Huangming Hong, Suporn Chuncharunee, Do Huyen Nga, Noorwati Sutandyo, Choon Kiat Ong, Michelle Limei Poon, Anand Jeyasekharan, Nagavalli Somasundaram, Matthew Lunning, Ritsuro Suzuki, Koji Izutsu, Eric Tse, Soon Thye Lim, Won Seog Kim   +22 more
doaj   +1 more source